NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin
Source: Yeo W, Lau TK, Kwok CC, et al. NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin. BMJ Supportive & Palliative Care, 29 January 2020. DOI:10.1136/bmjspcare-2019-002037
Published
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via
Are you a GP or Specialist Doctor, practising in UK, looking for:
- easy-to-digest, relevant updates and educational content
- a safe-space to share and collaborate with peers?
OnMedica is for you, sign up FOR FREE now!
No comments yet.